Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06280209
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-01-26
Brief Title:
A Phase 12 Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Organization Data
Organization:
BioMarin Pharmaceutical
Class:
INDUSTRY
Study ID:
351-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioMarin Pharmaceutical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None